| 发明名称 |
SELECTION OF HCV TREATMENT. |
| 摘要 |
<p>The present invention is based on the discovery of an association between the SNP genotype at the rs12979860 locus in the IL28B gene promoter and the probability of achieving a SVR in HC V-infected patients that are given a triple therapy treatment that contains peginterferon alfa-2a, ribavirin, and a HCV NS5B polymerase inhibitor.</p> |
| 申请公布号 |
MX2013011127(A) |
申请公布日期 |
2014.03.12 |
| 申请号 |
MX20130011127 |
申请日期 |
2012.03.28 |
| 申请人 |
F. HOFFMANN-LA ROCHE AG |
发明人 |
VICTOR IGLESIAS;DAVID IPE;JAMES THOMMES;YONGHONG ZHU |
| 分类号 |
A61K31/7056;A61K31/7068;A61K38/21;A61K45/06;A61P31/14;C12Q1/68 |
主分类号 |
A61K31/7056 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
